Edgewise Therapeutics Inc. (EWTX)
EWTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$36.28
-5.64% on the day
Market cap
$3.9B
Mid cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | EWTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001710072 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-04-02 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 419 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.8% |
| 1 month | -14.6% |
| 3 months | -2.4% |
| Year to date | +50.2% |
| 1 year | +153.4% |
| From 52-week high | -22.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc. Common Shares | $12.61 | -0.20% | $4.1B |
| TNGX | Tango Therapeutics Inc. | $22.22 | -8.07% | $3.7B |
| INDV | Indivior Pharmaceuticals Inc. | $35.42 | -1.77% | $4.2B |
| TLX | Telix Pharmaceuticals Limited | $10.92 | -3.28% | $3.7B |
| OGN | Organon & Co. Common Stock | $13.77 | 0.00% | $3.6B |
| DNTH | Dianthus Therapeutics Inc. | $77.58 | -4.89% | $4.3B |
| LEGN | Legend Biotech Corporation | $17.88 | +0.45% | $3.5B |
| AMLX | Amylyx Pharmaceuticals Inc. | $26.85 | -2.29% | $3.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier